Stay updated on Safety of Growth Hormone-Deficiency Treatment Clinical Trial
Sign up to get notified when there's something new on the Safety of Growth Hormone-Deficiency Treatment Clinical Trial page.

Latest updates to the Safety of Growth Hormone-Deficiency Treatment Clinical Trial page
- Check4 days agoChange DetectedThe changes add a glossary toggle and new QC-related metadata labels ('Last Update Submitted that Met QC Criteria', 'Revision: v3.4.0'), and remove older QC labels ('Last Update Submitted that met QC Criteria', 'No FEAR Act data', 'Revision: v3.3.4'). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 in the page header — No study data or content has changed, and the update is limited to metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedAdded a consolidated Locations section listing study sites by state (California, Colorado, Delaware, Florida, Michigan, Nevada, New York, North Carolina, Pennsylvania, Texas, Virginia, Washington) with a revision tag v3.3.3. The HHS Vulnerability Disclosure link was removed.SummaryDifference1%

- Check69 days agoChange DetectedRevision label updated to v3.3.2 (previously v3.2.0). This is a minor maintenance update with no changes to the study content.SummaryDifference0.0%

- Check76 days agoChange DetectedThe government funding/operating status warning has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check90 days agoChange DetectedNo significant changes detected in the page content; the study details and related information appear the same across screenshots.SummaryDifference0.3%

Stay in the know with updates to Safety of Growth Hormone-Deficiency Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Growth Hormone-Deficiency Treatment Clinical Trial page.